ArticleEuropean journal of neurology2025
Reference-Group Adjusted Behavioural Dysfunction Questionnaire Score Discriminates Highly Behavioural-Variant Frontotemporal Dementia From Major Depressive Disorder and Alzheimer's Disease Dementia.
Article in European journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundGiven the fact that behavioural variant frontotemporal dementia (bvFTD) is characterised by behavioural disorders, the assessment of these disorders is essential for early diagnosis of bvFTD. In this regard, the recently developed Behavioural Dysfunction Questionnaire (BDQ) that captures the bvFTD-specific behavioural disorders is promising in discriminating mild-stage bvFTD from other neurodegenerative and psychiatric disorders. In this study, we aimed to increase the discriminatory power of the BDQ by adaptation of its scoring depending on the reference group to bvFTD.
methodsIn this combined prospective and retrospective cross-sectional study, data of 241 patients [i.e., 50 patients with mild-stage bvFTD, 71 patients with major depressive disorder (MDD) and 120 patients with mild-stage Alzheimer's disease dementia (ADD)] were analysed. We calculated the BDQ score in two ways: (1) as the average score of the domains' mean scores and (2) by adjusting the scoring depending on the reference group by using machine learning techniques, validated by fivefold cross-validation.
resultsThe adjusted BDQ score showed a higher (bvFTD vs. MDD) or similar (bvFTD vs. ADD) discriminatory power than the unadjusted BDQ score, with a considerably smaller difference between cut-offs with at least 90% sensitivity and at least 90% specificity.
conclusionsWe recommend using adjusted BDQ scores when MDD or ADD are the reference groups to bvFTD. Similar approaches should be taken for other reference groups to bvFTD to best reflect the thinking of clinicians who have specific reference groups in mind as differential diagnoses to bvFTD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.